Sort
85,873 grants matching “alzheimers”
A regulome and transcriptome atlas of fetal and adult human neurogenesis
$5,548,451Panagiotis Roussos · Icahn School Of Medicine At Mount Sinai · RF1 · FY2021 · MH
Roles of Gray Matter Brain Aging and Small Vessel Disease in AD Pathophysiology
$5,546,075Howard J Aizenstein · University Of Pittsburgh At Pittsburgh · RF1 · FY2021 · AG
Longitudinal multicenter head-to-head harmonization of tau PET tracers
$5,532,594Tharick Pascoal · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AG
Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial of T3D-959 in Mild to Moderate Alzheimer's Disease Subjects
$5,526,539John Didsbury · T3d Therapeutics, Inc. · R01 · FY2021 · AG
Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial of T3D-959 in Mild to Moderate Alzheimer's Disease Subjects
$5,526,538John Didsbury · T3d Therapeutics, Inc. · R01 · FY2022 · AG
Dominantly Inherited Alzheimer's Network Trials Unit - Adaptive Prevention Trial
$5,525,079Randall J Bateman · Washington University · R01 · FY2014 · AG
Exploring the Role of the Brain Epigenome: Cognitive Decline and Life Experiences
$5,523,657David A Bennett · Rush University Medical Center · RF1 · FY2016 · AG
Alzheimer's Disease Connectome Project
$5,520,009Shi-Jiang Li · Medical College Of Wisconsin · UF1 · FY2016 · AG
National Longitudinal Study of Adolescent to Adult Health (Add Health): Wave VI Core Project
$5,511,491Robert A Hummer · Univ Of North Carolina Chapel Hill · U01 · FY2024 · AG
ACTIVE MIND: An adaptive clinical trial of cognitive training to improve function and delay dementia
$5,508,175Jerri Edwards · University Of South Florida · R01 · FY2022 · AG
Frontotemporal Dementia: Genes, Images, and Emotions
$5,506,891Maria Luisa Gorno Tempini · University Of California, San Francisco · P01 · FY2025 · AG
DIAN-TU: Next Generation Prevention Trial
$5,486,752Randall J Bateman · Washington University · R01 · FY2023 · AG
Core B: Outreach, Ascertainment, and Data Collection
$5,476,008Margaret A Pericak-Vance · University Of Miami School Of Medicine · U19 · FY2025 · AG
Johns Hopkins-Tufts Trial Innovation Center
$5,470,529Daniel F Hanley · Johns Hopkins University · U24 · FY2017 · TR
Improving causal inference in Alzheimer's Disease prevention research on modifiable risk factors: the Triangulation of Innovative Methods to EndAD (TIME-AD) project
$5,470,174Medellena Maria Glymour · Boston University Medical Campus · P01 · FY2025 · AG
Health, Aging and Dementia in South Africa: A Longitudinal Study (HAALSI)
$5,464,940Lisa F Berkman · Harvard University D/B/A Harvard School Of Public Health · P01 · FY2024 · AG
Precision Monitoring and Assessment in the Framingham Study: Cognitive, MRI, Genetic and Biomarker Precursors of AD & Dementia
$5,451,688Lindsay A. Farrer · Boston University Medical Campus · U19 · FY2022 · AG
The role of 24-hour activity cycles in preserving cognitive function and preventing Alzheimer's disease and related dementias
$5,450,271Keith M Diaz · Columbia University Health Sciences · RF1 · FY2022 · AG
Frontotemporal Dementia: Genes, Images, and Emotions
$5,446,505Maria Luisa Gorno Tempini · University Of California, San Francisco · P01 · FY2024 · AG
Alzheimer's Gut Microbiome Project
$5,424,083Rima F Kaddurah-Daouk · Duke University · U19 · FY2020 · AG
Vascular-immune mechanisms of cerebral amyloid angiopathy and Alzheimer's pathology
$5,423,836Andrew Chris Yang · J. David Gladstone Institutes · RF1 · FY2024 · NS
Core C: Clinical Core
$5,422,290Benjamin L Handen · University Of Pittsburgh At Pittsburgh · U19 · FY2023 · AG
Blood amyloid, tau, and neurodegeneration biomarkers and prediction of clinical onset, cognitive decline, and dementia diagnosis
$5,409,374Randall J Bateman · Washington University · R01 · FY2025 · AG
Biomarkers of Cognitive Decline Among Normal Individuals: The Biocard Cohort
$5,399,026Marilyn S Albert · Johns Hopkins University · U19 · FY2022 · AG
PREVENTION OF ALZHEIMER DEMENTIA & COGNITIVE DECLINE
$5,397,013John C S Breitner · University Of Washington · U01 · FY2006 · AG